跳到正文
原文
Medical Xpress·· 2026-10-19AI 评分40

大阪大学研究发现修饰抗体通过抑制中性粒细胞聚集减轻ANCA相关肾小球肾炎动物模型肾脏损伤

Curbing the neutrophil surge: New treatment offers hope for autoimmune diseases

AI 导读

大阪大学团队在《实验医学杂志》上发表研究,揭示了ANCA相关肾小球肾炎早期发病机制中,受损肾细胞信号吸引中性粒细胞形成病理性微环境并驱动炎症。研究人员在动物模型中测试修饰抗体,发现其通过减少Fcγ受体刺激成功降低了中性粒细胞过度激活,从而减轻了肾脏损伤。该发现为在疾病早期阻断严重肾损伤提供了潜在新治疗策略,有望开发副作用更少的靶向疗法。

正文
Curbing the neutrophil surge: New treatment offers hope for autoimmune diseases
Neutrophil–epithelial niches in the kidney in ANCA-associated vasculitis. A spatial transcriptomic cell map showing neutrophils (pink) accumulating around injured proximal tubular epithelial cells (yellow), forming a local pathogenic microenvironment termed a "neutrophil–epithelial niche." Other colors represent other renal and immune cell populations. Credit: Masayuki Nishide

When immunity works well, the body steers clear of infection and disease. However, when the immune system goes awry, healthy cells can often end up in the firing line. This can occur in autoimmune diseases like anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, a kidney disease in which ANCAs trigger destructive inflammation. However, there has been little information about the sequence of events associated with the early stages of disease.

Now, researchers from the University of Osaka have uncovered the first steps in the development of ANCA-associated glomerulonephritis. The researchers found that injured kidney cells send signals that attract immune cells, including neutrophils, which drive the spread of inflammation in the early stages. The findings are published in the Journal of Experimental Medicine.

Tracing inflammation at its source

Despite improvement in treatment options, current treatments for ANCA-associated glomerulonephritis carry risks ranging from side effects of prolonged use to treatment failure. Targeted treatments could offer better health outcomes for patients. However, to do so, researchers would need to clarify how the disease process starts to tackle the problems head-on.

"In ANCA-associated glomerulonephritis, the kidneys are frequently involved," explains lead author Masayuki Nishide. "This makes it an excellent candidate for studying the initial steps of the autoimmune disease process."

The researchers compared kidney samples from healthy donors and from patients with ANCA-associated glomerulonephritis who did not receive treatment. Using cutting-edge technology, they studied the sequence of events in disease progression while preserving cellular organization in the tissue samples.

"Our goal was to investigate how exactly the disease unfolds in the early stage so that we could attempt to stop it before significant damage is done," says senior author Atsushi Kumanogoh. "We were surprised to see that despite the normal appearance of the tissue, we could still detect changes at the cellular level."

Modified antibodies curb kidney injury

After finding that diseased organs displayed more damage compared to normal kidneys, the researchers aimed to replicate and treat the injury using a mouse model. The researchers found that excessive neutrophil activation is a key aspect of early disease, leading researchers to attempt to decrease neutrophil activation.

In turn, researchers modified antibodies and tested whether they could minimize stimulation of Fcγ receptors, which are integral to the development of the inflammatory process.

The results were promising, and the modified antibodies successfully reduced kidney injury in the model. These findings point to a potential new therapeutic strategy aimed at stopping the disease at its earliest stage, before severe kidney damage develops. It is hoped that continued developments in this area can offer patients new hope for potentially safer treatments with fewer side effects.

Publication details

Epitope-diverse autoantibodies induce neutrophil–epithelial niches driving kidney injury in ANCA-associated glomerulonephritis, Journal of Experimental Medicine (2026). DOI: 10.1084/jem.20260506

Journal information: Journal of Experimental Medicine

Key medical concepts

Injury to Kidney

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Curbing the neutrophil surge: New treatment offers hope for autoimmune diseases (2026, October 19) retrieved 19 October 2026 from https://medicalxpress.com/news/2026-10-curbing-neutrophil-surge-treatment-autoimmune.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com